Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Sander

Showing results (181-190 of 233) with videos related to

Pageof 24
Sort By:
Cancer Discovery|February 14, 2012
Genomic complexity and AKT dependence in serous ovarian cancerAphrothiti J Hanrahan, Nikolaus Schultz, Maggie L Westfal, et al.
Blood|March 1, 2007
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemiaValerio Fulci, Sabina Chiaretti, Marina Goldoni, et al.
Cancer Research|June 8, 2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersNicolaos Palaskas, Steven M Larson, Nikolaus Schultz, et al.
Nucleic Acids Research|October 25, 2019
Pathway Commons 2019 Update: integration, analysis and exploration of pathway dataIgor Rodchenkov, Ozgun Babur, Augustin Luna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancerGopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Nucleic Acids Research|May 17, 2021
PredictProtein - Predicting Protein Structure and Function for 29 YearsMichael Bernhofer, Christian Dallago, Tim Karl, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Nature Medicine|May 8, 2023
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectoriesDavide Placido, Bo Yuan, Jessica X Hjaltelin, et al.
Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.
Nature Methods|December 31, 2025
Pertpy: an end-to-end framework for perturbation analysisLukas Heumos, Yuge Ji, Lilly May, et al.
Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:
Pageof 24
Cancer Discovery|February 14, 2012
Genomic complexity and AKT dependence in serous ovarian cancerAphrothiti J Hanrahan, Nikolaus Schultz, Maggie L Westfal, et al.
Blood|March 1, 2007
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemiaValerio Fulci, Sabina Chiaretti, Marina Goldoni, et al.
Cancer Research|June 8, 2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersNicolaos Palaskas, Steven M Larson, Nikolaus Schultz, et al.
Nucleic Acids Research|October 25, 2019
Pathway Commons 2019 Update: integration, analysis and exploration of pathway dataIgor Rodchenkov, Ozgun Babur, Augustin Luna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancerGopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Nucleic Acids Research|May 17, 2021
PredictProtein - Predicting Protein Structure and Function for 29 YearsMichael Bernhofer, Christian Dallago, Tim Karl, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Nature Medicine|May 8, 2023
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectoriesDavide Placido, Bo Yuan, Jessica X Hjaltelin, et al.
Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.
Nature Methods|December 31, 2025
Pertpy: an end-to-end framework for perturbation analysisLukas Heumos, Yuge Ji, Lilly May, et al.
Pageof 24